1. Academic Validation
  2. Identifying therapeutic vulnerabilities in lung cancer: application of a chemistry-first approach

Identifying therapeutic vulnerabilities in lung cancer: application of a chemistry-first approach

  • Transl Lung Cancer Res. 2018 Sep;7(Suppl 3):S265-S269. doi: 10.21037/tlcr.2018.09.10.
Sharon R Pine 1 2 3 Bríd M Ryan 4
Affiliations

Affiliations

  • 1 Department of Pharmacology, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA.
  • 2 Department of Medicine, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA.
  • 3 Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA.
  • 4 Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-139047
    98.67%, GLUT8抑制剂